Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.
2.

Physicians' views on the role of smoking in smoking-related diseases: findings from cross-sectional studies from 1982-2014 in Estonia.

Pärna K, Põld M, Ringmets I.

Tob Induc Dis. 2017 Jul 19;15:31. doi: 10.1186/s12971-017-0136-9. eCollection 2017.

3.

Trends in smoking behaviour among Estonian physicians in 1982-2014.

Pärna K, Põld M, Ringmets I.

BMC Public Health. 2017 Jul 25;18(1):55. doi: 10.1186/s12889-017-4596-x. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.

4.
5.

Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination.

Smith KA, Qiu Z, Wong R, Tam VL, Tam BL, Joea DK, Quach A, Liu X, Pold M, Malyankar UM, Bot A.

Cancer Gene Ther. 2011 Jan;18(1):63-76. doi: 10.1038/cgt.2010.45. Epub 2010 Aug 20.

PMID:
20725097
6.

IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression.

Heuzé-Vourc'h N, Liu M, Dalwadi H, Baratelli FE, Zhu L, Goodglick L, Põld M, Sharma S, Ramirez RD, Shay JW, Minna JD, Strieter RM, Dubinett SM.

Biochem Biophys Res Commun. 2005 Jul 29;333(2):470-5.

PMID:
15950941
7.

Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.

Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM.

Cancer Res. 2004 Sep 15;64(18):6549-55.

8.

Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.

Krysan K, Dalwadi H, Sharma S, Põld M, Dubinett S.

Cancer Res. 2004 Sep 15;64(18):6359-62.

9.

Multifaceted roles of cyclooxygenase-2 in lung cancer.

Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM.

Drug Resist Updat. 2004 Jun;7(3):169-84. Review.

PMID:
15296859
10.

Cyclooxygenase-2-dependent expression of survivin in non-small cell lung cancer.

Krysan K, Dohadwala M, Luo J, Lin Y, Zhu L, Heuze-Vourc'h N, Goodglick L, Merchant F, Seligson D, Pold M, Strieter R, Sharma S, Dubinett S.

Chest. 2004 May;125(5 Suppl):140S. No abstract available.

PMID:
15136466
11.

Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.

Põld M, Zhu LX, Sharma S, Burdick MD, Lin Y, Lee PP, Põld A, Luo J, Krysan K, Dohadwala M, Mao JT, Batra RK, Strieter RM, Dubinett SM.

Cancer Res. 2004 Mar 1;64(5):1853-60.

12.

COX-2-dependent stabilization of survivin in non-small cell lung cancer.

Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Põld M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S.

FASEB J. 2004 Jan;18(1):206-8. Epub 2003 Nov 3.

PMID:
14597555
13.

Cyclooxygenase-2 in lung cancer.

Dubinett SM, Sharma S, Huang M, Dohadwala M, Pold M, Mao JT.

Prog Exp Tumor Res. 2003;37:138-62. Review. No abstract available.

PMID:
12795053
14.

Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism.

Batra RK, Lin Y, Sharma S, Dohadwala M, Luo J, Pold M, Dubinett SM.

Cancer Res. 2003 Feb 1;63(3):642-6.

15.

Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer.

Sharma S, Huang M, Dohadwala M, Pold M, Batra RK, Dubinett SM.

Methods Mol Med. 2003;75:723-36. No abstract available.

PMID:
12407775
16.

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion.

Dohadwala M, Batra RK, Luo J, Lin Y, Krysan K, Pold M, Sharma S, Dubinett SM.

J Biol Chem. 2002 Dec 27;277(52):50828-33. Epub 2002 Oct 21.

17.

Microarray identifies cyclo-oxygenase-2-dependent modulation of insulin-like growth factor binding protein-3 in non-small cell lung cancer cells.

Põld M, Dohadwala M, Luo J, Lin Y, Dubinett S.

Chest. 2002 Mar;121(3 Suppl):29S-30S. No abstract available.

PMID:
11893667
18.

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.

Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM.

J Biol Chem. 2001 Jun 15;276(24):20809-12. Epub 2001 Apr 24.

19.

Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma.

Ma HJ, Sjak-Shie NN, Vescio RA, Kaminsky M, Mikail A, Pold M, Parker K, Beksac M, Belson D, Moss TJ, Wu CH, Zhou J, Zhang L, Chen G, Said JW, Berenson JR.

Clin Cancer Res. 2000 Nov;6(11):4226-33.

20.

Cloning of the first invertebrate MAGE paralogue: an epitope that activates T-cells in humans is highly conserved in evolution.

Põld M, Põld A, Ma HJ, Sjak-Shieb NN, Vescio RA, Berensonb JR.

Dev Comp Immunol. 2000 Dec;24(8):719-31.

PMID:
10906385
21.

Identification of a new, unorthodox member of the MAGE gene family.

Põld M, Zhou J, Chen GL, Hall JM, Vescio RA, Berenson JR.

Genomics. 1999 Jul 15;59(2):161-7.

PMID:
10409427
22.

Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients.

Rettig MB, Ma HJ, Vescio RA, Põld M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR.

Science. 1997 Jun 20;276(5320):1851-4.

23.

Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.

Harro J, Põld M, Vasar E.

Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):62-7.

PMID:
2314484
24.

Central- and peripheral-type benzodiazepine receptors: similar regulation by stress and GABA receptor agonists.

Rägo L, Kiivet RA, Harro J, Pŏld M.

Pharmacol Biochem Behav. 1989 Apr;32(4):879-83.

PMID:
2552477
25.

Supplemental Content

Support Center